Annual Accounts Receivable
$28.97 B
+$11.61 B+66.85%
31 December 2023
Summary:
MetLife annual accounts receivable is currently $28.97 billion, with the most recent change of +$11.61 billion (+66.85%) on 31 December 2023. During the last 3 years, it has risen by +$11.82 billion (+68.94%). MET annual accounts receivable is now at all-time high.MET Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$31.44 B
-$377.00 M-1.18%
30 September 2024
Summary:
MetLife quarterly accounts receivable is currently $31.44 billion, with the most recent change of -$377.00 million (-1.18%) on 30 September 2024. Over the past year, it has increased by +$2.47 billion (+8.53%). MET quarterly accounts receivable is now -1.18% below its all-time high of $31.82 billion, reached on 30 June 2024.MET Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MET Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +8.5% |
| 3 y3 years | +68.9% | +83.3% |
| 5 y5 years | +41.7% | +53.8% |
MET Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.9% | -1.2% | +83.3% |
| 5 y | 5 years | at high | +68.9% | -1.2% | +83.3% |
| alltime | all time | at high | +116.6% | -1.2% | +387.9% |
MetLife Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.44 B(-1.2%) |
| June 2024 | - | $31.82 B(+6.1%) |
| Mar 2024 | - | $29.99 B(+3.5%) |
| Dec 2023 | $28.97 B(+66.8%) | $28.97 B(+52.5%) |
| Sept 2023 | - | $19.00 B(+2.5%) |
| June 2023 | - | $18.53 B(-0.9%) |
| Mar 2023 | - | $18.69 B(+7.6%) |
| Dec 2022 | $17.36 B(+1.3%) | $17.36 B(-1.7%) |
| Sept 2022 | - | $17.67 B(-0.6%) |
| June 2022 | - | $17.77 B(-0.9%) |
| Mar 2022 | - | $17.93 B(+4.5%) |
| Dec 2021 | $17.15 B(-4.0%) | $17.15 B(-3.7%) |
| Sept 2021 | - | $17.82 B(-2.3%) |
| June 2021 | - | $18.24 B(-2.6%) |
| Mar 2021 | - | $18.73 B(+4.8%) |
| Dec 2020 | $17.87 B(-12.6%) | $17.87 B(-13.7%) |
| Sept 2020 | - | $20.71 B(-0.7%) |
| June 2020 | - | $20.85 B(-1.8%) |
| Mar 2020 | - | $21.22 B(+3.8%) |
| Dec 2019 | $20.44 B(+4.1%) | $20.44 B(-1.4%) |
| Sept 2019 | - | $20.72 B(+1.5%) |
| June 2019 | - | $20.43 B(-0.9%) |
| Mar 2019 | - | $20.61 B(+4.9%) |
| Dec 2018 | $19.64 B(+6.6%) | $19.64 B(-0.9%) |
| Sept 2018 | - | $19.82 B(+1.1%) |
| June 2018 | - | $19.61 B(+1.2%) |
| Mar 2018 | - | $19.37 B(+5.1%) |
| Dec 2017 | $18.42 B(+19.3%) | $18.42 B(-0.9%) |
| Sept 2017 | - | $18.59 B(-29.8%) |
| June 2017 | - | $26.49 B(+2.2%) |
| Mar 2017 | - | $25.92 B(+67.8%) |
| Dec 2016 | $15.45 B(-32.0%) | $15.45 B(-41.0%) |
| Sept 2016 | - | $26.18 B(+0.5%) |
| June 2016 | - | $26.04 B(-6.5%) |
| Mar 2016 | - | $27.84 B(+22.6%) |
| Dec 2015 | $22.70 B(+2.1%) | $22.70 B(-12.0%) |
| Sept 2015 | - | $25.81 B(+3.8%) |
| June 2015 | - | $24.87 B(+2.8%) |
| Mar 2015 | - | $24.19 B(+8.7%) |
| Dec 2014 | $22.24 B(+1.8%) | $22.24 B(-6.6%) |
| Sept 2014 | - | $23.81 B(+0.4%) |
| June 2014 | - | $23.73 B(+3.0%) |
| Mar 2014 | - | $23.03 B(+5.4%) |
| Dec 2013 | $21.86 B | $21.86 B(-6.9%) |
| Sept 2013 | - | $23.47 B(+0.8%) |
| June 2013 | - | $23.28 B(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $23.05 B(+6.6%) |
| Dec 2012 | $21.63 B(-3.8%) | $21.63 B(-5.7%) |
| Sept 2012 | - | $22.94 B(-4.3%) |
| June 2012 | - | $23.97 B(+0.9%) |
| Mar 2012 | - | $23.76 B(+5.7%) |
| Dec 2011 | $22.48 B(+13.4%) | $22.48 B(-2.8%) |
| Sept 2011 | - | $23.14 B(+9.8%) |
| June 2011 | - | $21.07 B(+3.7%) |
| Mar 2011 | - | $20.32 B(+2.4%) |
| Dec 2010 | $19.83 B(+18.4%) | $19.83 B(+9.1%) |
| June 2010 | - | $18.18 B(+3.5%) |
| Mar 2010 | - | $17.55 B(+4.8%) |
| Dec 2009 | $16.75 B(-1.3%) | $16.75 B(-0.9%) |
| Sept 2009 | - | $16.90 B(+1.0%) |
| June 2009 | - | $16.73 B(-9.6%) |
| Mar 2009 | - | $18.51 B(+9.1%) |
| Dec 2008 | $16.97 B(+26.9%) | $16.97 B(-5.0%) |
| Sept 2008 | - | $17.86 B(+16.0%) |
| June 2008 | - | $15.40 B(+2.7%) |
| Mar 2008 | - | $15.00 B(+12.2%) |
| Dec 2007 | $13.37 B(-7.7%) | $13.37 B(-19.2%) |
| Sept 2007 | - | $16.55 B(+8.2%) |
| June 2007 | - | $15.30 B(-1.8%) |
| Mar 2007 | - | $15.58 B(+7.5%) |
| Dec 2006 | $14.49 B | $14.49 B(-0.0%) |
| Sept 2006 | - | $14.49 B(+9.7%) |
| June 2006 | - | $13.22 B(+3.8%) |
| Mar 2006 | - | $12.73 B(-11.5%) |
| Sept 2005 | - | $14.39 B(+84.0%) |
| June 2005 | - | $7.82 B(+4.1%) |
| Mar 2005 | - | $7.51 B(+6.0%) |
| Sept 2004 | - | $7.09 B(-6.3%) |
| June 2004 | - | $7.57 B(+0.2%) |
| Mar 2004 | - | $7.55 B(+5.9%) |
| Sept 2003 | - | $7.13 B(-5.0%) |
| June 2003 | - | $7.51 B(-5.7%) |
| Mar 2003 | - | $7.97 B(-2.4%) |
| Sept 2002 | - | $8.16 B(-0.1%) |
| June 2002 | - | $8.17 B(+0.7%) |
| Mar 2002 | - | $8.11 B(+0.6%) |
| Sept 2001 | - | $8.06 B(-0.9%) |
| June 2001 | - | $8.14 B(-7.5%) |
| Mar 2001 | - | $8.80 B(+36.5%) |
| Sept 2000 | - | $6.45 B(-22.5%) |
| June 2000 | - | $8.32 B(-7.9%) |
| Mar 2000 | - | $9.03 B |
FAQ
- What is MetLife annual accounts receivable?
- What is the all time high annual accounts receivable for MetLife?
- What is MetLife quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for MetLife?
- What is MetLife quarterly accounts receivable year-on-year change?
What is MetLife annual accounts receivable?
The current annual accounts receivable of MET is $28.97 B
What is the all time high annual accounts receivable for MetLife?
MetLife all-time high annual accounts receivable is $28.97 B
What is MetLife quarterly accounts receivable?
The current quarterly accounts receivable of MET is $31.44 B
What is the all time high quarterly accounts receivable for MetLife?
MetLife all-time high quarterly accounts receivable is $31.82 B
What is MetLife quarterly accounts receivable year-on-year change?
Over the past year, MET quarterly accounts receivable has changed by +$2.47 B (+8.53%)